Hims & Hers Health, Inc.

HIMS · NYSE · ·

तुलना करें

$20.81+8.7%11 नव॰ बंद भाव

30 सितंबर 2026 तक के आँकड़े, 9 नवंबर 2026 को दाखिल 10-Q से

1W: -20.0%
1M: -30.0%

Hims & Hers Health, Inc. (HIMS) शेयर — क्या यह अच्छा व्यवसाय है? — InspectStocks

Hims & Hers Health, Inc.

HIMS · NYSE · ·

तुलना करें

$20.81+8.7%11 नव॰ बंद भाव

30 सितंबर 2026 तक के आँकड़े, 9 नवंबर 2026 को दाखिल 10-Q से

1W: -20.0%
1M: -30.0%

Just reported

Q3 2026 results

From Hims & Hers Health's results release of 9 नवंबर 2026; its quarterly report has since been filed.

Revenue
Actual
$890.4M
+49% y/y
+18% q/q
Guided
$890M
midpoint
Within guide0.0%
EPS, GAAP
Actual
-$0.14
Guided
—
No guide given
Operating income, GAAP
Actual
-$66.1M
Guided
—
No guide given

Company outlook

Q4 2026

Revenue$875M – $895M+43% y/y First given

Full year 2026

Revenue$3.13B – $3.15B+34% y/y Lowered -1.9%

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes Hims & Hers Health is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Drug Manufacturers Specialty and Generic

Graded A or B and worth $2B or more: A first, then the largest.

All 78 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

कमाई कैसे होती है

Sales to customers in the United States87%
Sales to customers outside the United States13%

आमदनी के हिस्से quarter ended March 31, 2026 के अनुमान हैं, किसी दाख़िल रिपोर्ट के आँकड़े नहीं।

मुकाबला किनसे है

क्या बेचती है5

Prescription treatments
Medicines prescribed by clinicians for conditions including sexual health, hair loss, hormone health, weight loss, skin conditions, and mental health. Prescriptions may be filled by company-owned or partner pharmacies.
Weight-loss care and medicines
Weight-loss medicines, including access to branded medicines and, on a limited scale, compounded medicines, with a membership that can include ongoing clinician support.
Non-prescription products
Products such as skin care, hair care, sexual wellness products, cosmetics, and supplements, sold under Hims & Hers or co-branded with manufacturers.

2 और दिखाएँ

Laboratory testing
Testing services that measure health markers and provide results to support health assessments and follow-up care with clinicians.
Telehealth consultations and follow-up care
Remote consultations with licensed healthcare professionals, who assess customers and may prescribe medication or provide ongoing care.

कौन खरीदता है3

Consumers who buy prescription treatments and related care directly through Hims & Hers websites and apps; many choose recurring subscriptions and are billed when products ship or services are provided.
Consumers who make one-time purchases through the websites, apps, or retail stores.
Retail partners that buy or sell Hims & Hers non-prescription products in stores and on third-party websites.

किस पर टिका है, और क्या इसे तोड़ सकता है

कारोबार किन चीज़ों पर टिका है

1In the United States, clinical care depends on contractual relationships with independent affiliated medical groups, which retain control over medical decisions.
2Fulfilling prescriptions depends on licensed company-owned and partner pharmacies, product manufacturers, and suppliers.
3The business depends on access to the internet, cloud and payment providers, and systems that handle sensitive customer health information.
4Selling and fulfilling medicines, compounded drugs, and laboratory tests depends on healthcare, pharmacy, product-safety, and privacy rules in each market.

क्या ग़लत हो सकता है

1Regulators may restrict compounded medicines, including weight-loss drugs. The company received warning letters concerning promotion of compounded products, and the United States Food and Drug Administration said it intended to restrict certain ingredients for mass-marketed compounded drugs.
2Changes in telehealth and medical-practice rules could disrupt the company’s arrangements with affiliated medical groups or limit how clinicians assess patients and prescribe medicines.
3A data breach or failure to comply with changing privacy laws could expose sensitive health information, trigger penalties or lawsuits, and damage customer trust.

पूरे वित्तीय विवरण →

Hims & Hers Health, Inc. के बारे में

Customers use Hims & Hers websites and apps to find treatments, answer health questions, and connect with licensed healthcare professionals. When appropriate, clinicians prescribe medication, which Hims & Hers or other licensed pharmacies ship to customers; customers can also buy non-prescription products and laboratory testing. In the United States, independent medical groups make clinical decisions, while Hims & Hers provides administrative and technology services. It had 2.891 million subscribers (June 30, 2026, high), meaning customers with recurring billing; monthly revenue per average subscriber was $92 (three months ended June 30, 2026, high), a measure that also includes revenue from one-time purchases.

मुख्यालय: San Francisco, California
स्थापना: 2017
कर्मचारी: 2,442 (December 31, 2025, high)
सूचीबद्ध: NYSE
वित्त वर्ष का अंत: December 31

Hims & Hers Health, Inc. की अपनी रिपोर्टों से बना, जो अमेरिकी प्रतिभूति और विनिमय आयोग (SEC) में दाखिल की गईं। आँकड़े जैसे बताए गए, और प्रति-शेयर इतिहास आज के शेयर आधार पर पुनर्गणित। यह एक व्यवसाय का वर्णन है — यह निवेश सलाह नहीं है और न ही कुछ खरीदने या बेचने की सिफ़ारिश।

Just reported